Singapore markets open in 1 hour
Straits Times Index
3,384.29 +20.61 (+0.61%) S&P 500
4,136.48 -43.28 (-1.04%) Dow
33,926.01 -127.89 (-0.38%) Nasdaq
12,006.96 -193.84 (-1.59%) BTC-USD
22,957.00 -372.74 (-1.60%) CMC Crypto 200
535.42 -1.43 (-0.27%)
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.28B |
| Enterprise value | 1.00B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.26 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -2.70 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.12 |
| 52-week change 3 | -51.46% |
| S&P500 52-week change 3 | -7.75% |
| 52-week high 3 | 18.73 |
| 52-week low 3 | 5.42 |
| 50-day moving average 3 | 6.69 |
| 200-day moving average 3 | 9.97 |
Share statistics
| Avg vol (3-month) 3 | 5.12M |
| Avg vol (10-day) 3 | 7.16M |
| Shares outstanding 5 | 157.84M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 107.73M |
| % held by insiders 1 | 0.52% |
| % held by institutions 1 | 118.20% |
| Shares short (12 Jan 2023) 4 | 20.12M |
| Short ratio (12 Jan 2023) 4 | 5.53 |
| Short % of float (12 Jan 2023) 4 | 13.39% |
| Short % of shares outstanding (12 Jan 2023) 4 | 12.74% |
| Shares short (prior month 14 Dec 2022) 4 | 19.08M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 25 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -35.58% |
| Return on equity (ttm) | -71.41% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -383.47M |
| Net income avi to common (ttm) | -389.9M |
| Diluted EPS (ttm) | -2.30 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 360.17M |
| Total cash per share (mrq) | 2.28 |
| Total debt (mrq) | 80.11M |
| Total debt/equity (mrq) | 20.35 |
| Current ratio (mrq) | 4.67 |
| Book value per share (mrq) | 2.49 |
Cash flow statement
| Operating cash flow (ttm) | -268.94M |
| Levered free cash flow (ttm) | -155.24M |
© 2023 Yahoo. All rights reserved.
